Extracellular matrix protein 1 is correlated to carcinogenesis and lymphatic metastasis of human gastric cancer

World Journal of Surgical Oncology

Volumn 12, Issue 1, 2014, Pages

  Wu, Qiuwan ^a   Li, Xiaohong ^a   Yang, Haiyan ^a   Lu, Chuanhui ^a   You, Jun ^a   Zhang, Zhiming ^a  

^a FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

Extracellular matrix protein 1 (ECM1); Gastric cancer; Immunohistochemistry; Lymphatic microvessel density (LMVD); Real time PCR (RT PCR)

Indexed keywords

EXTRACELLULAR MATRIX PROTEIN 1; MESSENGER RNA; MONOCLONAL ANTIBODY D2-40; SYNAPSIN I; UNCLASSIFIED DRUG; ECM1 PROTEIN, HUMAN; SCLEROPROTEIN;

ADULT; ARTICLE; CANCER RESEARCH; CANCER STAGING; CAPILLARY DENSITY; CARCINOGENESIS; CLINICAL PROTOCOL; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; LYMPH VESSEL ENDOTHELIUM; LYMPHATIC MICROVESSEL DENSITY; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; STOMACH CANCER; TUMOR INVASION; CASE CONTROL STUDY; CELL TRANSFORMATION; COMPARATIVE STUDY; ENZYME IMMUNOASSAY; FOLLOW UP; GENETICS; LYMPH VESSEL; METABOLISM; MICROVASCULATURE; MIDDLE AGED; PATHOLOGY; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH; STOMACH TUMOR;

CASE-CONTROL STUDIES; CELL TRANSFORMATION, NEOPLASTIC; EXTRACELLULAR MATRIX PROTEINS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPHATIC METASTASIS; LYMPHATIC VESSELS; MALE; MICROVESSELS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STOMACH; STOMACH NEOPLASMS;

EID: 84899966749     PISSN: None     EISSN: 14777819     Source Type: Journal    
DOI: 10.1186/1477-7819-12-132     Document Type: Article

References (21)

1. Al-Rawi MA, Jiang WG. Lymphangiogenesis and cancer metastasis. Front Biosci 2011, 16:723-739.
2. Maby-El Hajjami H, Petrova TV. Developmental and pathological lymphangiogenesis: from models to human disease. Histochem Cell Biol 2008, 130:1063-1078. 10.1007/s00418-008-0525-5, 18946678.
3. Adams RH, Alitalo K. Molecular regulation of angiogenesis and lymphangiogenesis. Nat Rev Mol Cell Biol 2007, 8:464-478. 10.1038/nrm2183, 17522591.
4. Zhuang Z, Jian P, Longjiang L, Bo H, Hongwei Z. Identification of oral cancer cell-induced changes in gene expression profile of lymphatic endothelial cell. Cancer Invest 2008, 26:1002-1007. 10.1080/07357900802087234, 18798059.
5. Achen MG, Stacker SA. Molecular control of lymphatic metastasis. Ann N Y Acad Sci 2008, 1131:225-234. 10.1196/annals.1413.020, 18519975.
6. Kim JH, Park SS, Park SH, Kim SJ, Mok YJ, Kim CS, Lee JH, Kim YS. Clinical significance of immunohistochemically-identified lymphatic and/or blood vessel tumor invasion in gastric cancer. J Surg Res 2010, 162:177-183. 10.1016/j.jss.2009.07.015, 20031164.
7. Van der Auwera I, Cao Y, Tille JC, Pepper MS, Jackson DG, Fox SB, Harris AL, Dirix LY, Vermeulen PB. First international consensus on the methodology of lymphangiogenesis quantification in solid human tumours. Br J Cancer 2006, 95:1611-1625. 10.1038/sj.bjc.6603445, 2360768, 17117184.
8. Weidner N. Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors. Breast Cancer Res Treat 1995, 36:169-180. 10.1007/BF00666038, 8534865.
9. Mathieu E, Meheus L, Raymackers J, Merregaert J. Characterization of the osteogenic stromal cell line MN7: identification of secreted MN7 proteins using two-dimensional polyacrylamide gel electrophoresis, western blotting, and microsequencing. J Bone Miner Res 1994, 9:903-913.
10. Chan I, Liu L, Hamada T, Sethuraman G, McGrath JA. The molecular basis of lipoid proteinosis: mutations in extracellular matrix protein 1. Exp Dermatol 2007, 16:881-890. 10.1111/j.1600-0625.2007.00608.x, 17927570.
11. Uchida T, Hayashi H, Inaoki M, Miyamoto T, Fujimoto W. A failure of mucocutaneous lymphangiogenesis may underlie the clinical features of lipoid proteinosis. Br J Dermatol 2007, 156:152-157. 10.1111/j.1365-2133.2006.07583.x, 17199583.
12. Han Z, Ni J, Smits P, Underhill CB, Xie B, Chen Y, Liu N, Tylzanowski P, Parmelee D, Feng P, Ding I, Gao F, Gentz R, Huylebroeck D, Merregaert J, Zhang L. Extracellular matrix protein 1 (ECM1) has angiogenic properties and is expressed by breast tumor cells. FASEB J 2001, 15:988-994. 10.1096/fj.99-0934com, 11292659.
13. Wu QW, She HQ, Liang J, Huang YF, Yang QM, Yang QL, Zhang ZM. Expression and clinical significance of extracellular matrix protein 1 and vascular endothelial growth factor-C in lymphatic metastasis of human breast cancer. BMC Cancer 2012, 12:47. 10.1186/1471-2407-12-47, 3292501, 22284579.
14. Wang L, Yu J, Ni J, Xu XM, Wang J, Ning H, Pei XF, Chen J, Yang S, Underhill CB, Liu L, Liekens J, Merregaert J, Zhang L. Extracellular matrix protein 1 (ECM1) is over-expressed in malignant epithelial tumors. Cancer Lett 2003, 200:57-67. 10.1016/S0304-3835(03)00350-1, 14550953.
15. Suzuki H, Onimaru M, Yonemitsu Y, Maehara Y, Nakamura S, Sueishi K. Podoplanin in cancer cells is experimentally able to attenuate prolymphangiogenic and lymphogenous metastatic potentials of lung squamoid cancer cells. Mol Cancer 2010, 9:287. 10.1186/1476-4598-9-287, 2987985, 21034514.
16. Fohn LE, Rodriguez A, Kelley MC, Ye F, Shyr Y, Stricklin G, Robbins JB. D2-40 lymphatic marker for detecting lymphatic invasion in thin to intermediate thickness melanomas: association with sentinel lymph node status and prognostic value-a retrospective case study. J Am Acad Dermatol 2011, 64:336-345. 10.1016/j.jaad.2010.03.005, 21238827.
17. Niakosari F, Kahn HJ, Marks A, From L. Detection of lymphatic invasion in primary melanoma with monoclonal antibody D2-40: a new selective immunohistochemical marker of lymphatic endothelium. Arch Dermatol 2005, 141:440-444.
18. Cueni LN, Hegyi I, Shin JW, Albinger-Hegyi A, Gruber S, Kunstfeld R, Moch H, Detmar M. Tumor lymphangiogenesis and metastasis to lymph nodes induced by cancer cell expression of podoplanin. Am J Pathol 2010, 177:1004-1016. 10.2353/ajpath.2010.090703, 2913355, 20616339.
19. Chen H, Jia WD, Li JS, Wang W, Xu GL, Ma JL, Ren WH, Ge YS, Yu JH, Liu WB, Zhang CH, Wang YC. Extracellular matrix protein 1, a novel prognostic factor, is associated with metastatic potential of hepatocellular carcinoma. Med Oncol 2011, Suppl 1:s318-s325.
20. Kebebew E, Peng M, Reiff E, Duh QY, Clark OH, McMillan A. ECM1 and TMPRSS4 are diagnostic markers of malignant thyroid neoplasms and improve the accuracy of fine needle aspiration biopsy. Ann Surg 2005, 242:353-361. discussion 361-353, 1357743, 16135921.
21. Lal G, Hashimi S, Smith BJ, Lynch CF, Zhang L, Robinson RA, Weigel RJ. Extracellular matrix 1 (ECM1) expression is a novel prognostic marker for poor long-term survival in breast cancer: a Hospital-based Cohort Study in Iowa. Ann Surg Oncol 2009, 16:2280-2287. 10.1245/s10434-009-0533-2, 19521735.